Alterations in TGF-β signaling have been implicated in the pathogenesis of several neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS) [5]. Here, TGFB1 is linked to Alzheimer disease.